P

Inventor

TOTH CAROL A

US12 patents
⚠️ This page may combine multiple inventors who share the name “TOTH CAROL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEW ENGLAND DEACONESS HOSPITAL

3 patents
US4914021AApr 3, 1990

Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses

NEW ENGLAND DEACONESS HOSPITAL59 citations96
US5241052AAug 31, 1993

Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses

NEW ENGLAND DEACONESS HOSPITAL0 citations52
US5204450AApr 20, 1993

Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses

NEW ENGLAND DEACONESS HOSPITAL0 citations52

APPLIED BIOTECHNOLOGY INC

3 patents
US5281697AJan 25, 1994

CEA-binding protein and uses thereof

APPLIED BIOTECHNOLOGY INC0 citations45
US5278290AJan 11, 1994

Binding protein for CEA and uses thereof

APPLIED BIOTECHNOLOGY INC0 citations45
US5245017ASep 14, 1993

Method for isolating CEA-binding protein

APPLIED BIOTECHNOLOGY INC0 citations45

STRYKER CORP

2 patents
US7390498B2Jun 24, 2008

Method of forming bone with porous βtricalcium phosphate granules

STRYKER CORP59 citations95
US7357941B2Apr 15, 2008

Method of delivering a bioactive agent with porous β-tricalcium phosphate granules

STRYKER CORP52 citations94

T CELL SCIENCES INC

2 patents
US5976540ANov 2, 1999

Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions

T CELL SCIENCES INC54 citations95
US5856300AJan 5, 1999

Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions

T CELL SCIENCES INC58 citations95

AVANT IMMUNOTHERAPEUTICS INC

1 patent
US6193979B1Feb 27, 2001

Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands

AVANT IMMUNOTHERAPEUTICS INC67 citations95

AVANT IMMUNOTHERPEUTICS INC

1 patent
US6169068B1Jan 2, 2001

Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

AVANT IMMUNOTHERPEUTICS INC65 citations86